Methotrexate vs Cyclosporin A as a single agent for graft-versus-host disease prophylaxis in pediatric patients with hematological malignancies undergoing allogeneic bone marrow transplantation from HLA-identical siblings: a single-center analysis i
about
Chronic graft-versus-host disease: where is promise for the future?Prophylactic and therapeutic treatment of graft-versus-host disease in Japan.Low-dose methotrexate may preserve a stronger antileukemic effect than that of cyclosporine after modified donor lymphocyte infusion in unmanipulated haploidentical HSCT.Outcomes of matched sibling donor bone marrow transplantation in children using single-agent calcineurin inhibitors as prophylaxis for graft versus host disease.
P2860
Methotrexate vs Cyclosporin A as a single agent for graft-versus-host disease prophylaxis in pediatric patients with hematological malignancies undergoing allogeneic bone marrow transplantation from HLA-identical siblings: a single-center analysis i
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年学术文章
@wuu
2003年学术文章
@zh
2003年学术文章
@zh-cn
2003年学术文章
@zh-hans
2003年学术文章
@zh-my
2003年学术文章
@zh-sg
2003年學術文章
@yue
2003年學術文章
@zh-hant
name
Methotrexate vs Cyclosporin A ...... gs: a single-center analysis i
@en
Methotrexate vs Cyclosporin A ...... gs: a single-center analysis i
@nl
type
label
Methotrexate vs Cyclosporin A ...... gs: a single-center analysis i
@en
Methotrexate vs Cyclosporin A ...... gs: a single-center analysis i
@nl
prefLabel
Methotrexate vs Cyclosporin A ...... gs: a single-center analysis i
@en
Methotrexate vs Cyclosporin A ...... gs: a single-center analysis i
@nl
P2093
P2860
P356
P1476
Methotrexate vs Cyclosporin A ...... gs: a single-center analysis i
@en
P2093
P2860
P2888
P304
P356
10.1038/SJ.BMT.1704051
P407
P577
2003-07-01T00:00:00Z